https://www.selleckchem.com/pr....oducts/relacorilant.
5% (n=25) and 15.3% (n=1 of the patients, respectively. In multivariate analysis, we found that PSA RR≥ 30% in patients had a statistically significant advantage in terms of PFS ( HR 0.38, 95% CI (0.13-0.71;p=0.03). In conclusion, 30% PSA RR was significantly associated with a better PFS. In conclusion, 30% PSA RR was significantly associated with a better PFS. To explore the associations between the expressions of micro ribonucleic acid (miR)-135 and miR-92a and the pathogenesis of prostate cancer, as well as their clinical sign
Like
Comment
Share
